elite research bpc-157 BPC-157 vs TB-500: Research Peptide
Description
Animal studies on BPC-157 have demonstrated a favorable safety profile, with no established LD50 (lethal dose) and no documented organ toxicity, carcinogenicity, or mutagenicity at tested doses
For research protocols requiring a fixed 1:1 ratio of BPC-157 and TB-500, a pre-blended vial eliminates the separate reconstitution and mixing steps, reducing preparation variability and the risk of cross-contamination between vials
Are there alternatives to injections
2016 Apr;68(4):91523
